| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |